Cargando…

Here Is the Case for the Urge in Administrative Claims Database Research About Overactive Bladder Therapies

Detalles Bibliográficos
Autores principales:	Szeinbach, Sheryl L., Jackson, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2008
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438358/ https://www.ncbi.nlm.nih.gov/pubmed/18439053 http://dx.doi.org/10.18553/jmcp.2008.14.3.309

Ejemplares similares

Overactive Bladder Disease: The Urge for Better Therapies
por: Thomas, Lisa, et al.
Publicado: (2008)

Urge suppression and modified fluid consumption in the management of female overactive bladder symptoms
por: Pal, Manidip, et al.
Publicado: (2021)

Impact of mirabegron extended-release on the treatment of overactive bladder with urge urinary incontinence, urgency, and frequency
por: Lee, Raymond T, et al.
Publicado: (2013)

Treatment success for overactive bladder with urinary urge incontinence refractory to oral antimuscarinics: a review of published evidence
por: Campbell, Jonathan D, et al.
Publicado: (2009)

The exoskeletons are here
por: Ferris, Daniel P
Publicado: (2009)

The James Lind Initiative: books, websites and databases to promote critical thinking about treatment claims, 2003 to 2018
por: Chalmers, Iain, et al.
Publicado: (2019)

Effect of Neuro-Adaptive Electrostimulation Therapy versus Sham for Refractory Urge Urinary Incontinence Due to Overactive Bladder: A Randomized Single-Blinded Trial
por: Zapico, Álvaro, et al.
Publicado: (2023)

Retinal Research in Latin America: How Did We Get Here?
por: AREVALO, J. Fernando
Publicado: (2017)

Health promotion for children, mothers and families: here’s why we should “think about it before conception”
por: Corchia, Carlo, et al.
Publicado: (2013)

Overactive bladder
por: Wallace, Karen M., et al.
Publicado: (2015)

Comment on: Safety and efficacy of mirabegron: analysis of a large integrated clinical trial database of patients with overactive bladder receiving mirabegron, antimuscarinics, or placebo
por: Scandura, Carmen, et al.
Publicado: (2020)

Nephron sparing surgery: Is here to stay
por: Gopalakrishnan, Ganesh
Publicado: (2007)

Cancer stem cells: here, there, and everywhere
por: Lodestijn, Sophie C., et al.
Publicado: (2018)

Editorial commentary on “Safety and Efficacy of Mirabegron: Analysis of a Large Integrated Clinical Trial Database of Patients with Overactive Bladder Receiving Mirabegron, Antimuscarinics, or Placebo”
por: Yamanishi, Tomonori, et al.
Publicado: (2020)

Commentary: Extrapleural pneumonectomy during myasthenic crisis: The urge to go big or go home
por: Abbas, Abbas E.
Publicado: (2020)

Increasing reinfections and decreasing effectiveness of COVID-19 vaccines urge the need for vaccine customization
por: Dewan, Syed Masudur Rahman, et al.
Publicado: (2022)

Adherence and persistence of mirabegron and anticholinergic therapies in patients with overactive bladder: a real‐world claims data analysis
por: Sussman, D., et al.
Publicado: (2017)

Treatment Patterns for Patients on Overactive Bladder Therapy: A Retrospective Statistical Analysis Using Canadian Claims Data
por: Wagg, Adrian, et al.
Publicado: (2016)

Limited Funds for Bladder Cancer Research and What Can We Do About It
por: Boormans, Joost L., et al.
Publicado: (2016)

Cardiovascular risk profile in individuals initiating treatment for overactive bladder – Challenges and learnings for comparative analysis using linked claims and electronic medical record databases
por: Vonesh, E., et al.
Publicado: (2018)

Postmenopausal overactive bladder
por: Tomaszewski, Jacek
Publicado: (2014)

Urodynamic Detrusor Overactivity in Patients with Overactive Bladder Symptoms
por: Al-Ghazo, Mohammed A., et al.
Publicado: (2011)

Overactive Bladder: Pathophysiology, Diagnostics, and Therapies
por: Heesakkers, John P. F. A., et al.
Publicado: (2011)

Effect of co-administration of BRL-37344 and tadalafil on reduction of overactive bladder symptoms after induction of detrusor overactivity in mice
por: de Carvalho, Marcos Fiuza, et al.
Publicado: (2019)

ICU Cornerstone: High frequency ventilation is here to stay
por: Rimensberger, Peter C
Publicado: (2003)

Precision medicine is here, break out your wallet
por: Hafez, Nabil
Publicado: (2014)

Here, the huge rainbow within the COVID-19 storm
por: Capua, Ilaria, et al.
Publicado: (2020)

CXCR3: Here to stay to enhance cancer immunotherapy?
por: Rogava, Meri, et al.
Publicado: (2019)

Commentary: Macular hole surgery – A tweak here and there
por: Vibhute, Giriraj, et al.
Publicado: (2022)

bTB eradication in Ireland: where to from here?
por: More, Simon J.
Publicado: (2023)

Where to Draw the LINE—Are Retrotransposable Elements Here to Stay?
por: Bergin, Christopher J., et al.
Publicado: (2023)

On the functional anatomy of the urge-for-action
por: Jackson, Stephen R., et al.
Publicado: (2011)

Physician-patient communication about overactive bladder: Results of an observational sociolinguistic study
por: Hahn, Steven R., et al.
Publicado: (2017)

A Review of Research Studies Using Data from the Administrative Claims Databases in Japan
por: Fujinaga, Jun, et al.
Publicado: (2022)

International health library associations urge the ICMJE to seek information specialists as peer reviewers for knowledge synthesis publications
por: Iverson, Sandy, et al.
Publicado: (2021)

Impact of Mirabegron Administration on the Blood Pressure and Pulse Rate in Patients with Overactive Bladder
por: Ito, Hidenori, et al.
Publicado: (2022)

Hemofiltration in sepsis: where do we go from here?
por: Kellum , John A, et al.
Publicado: (2000)

Good-bye CRRT, here comes SLED? ... not so fast!
por: Joannidis, Michael
Publicado: (2012)

Endoscopic Ultrasound-Guided Liver Biopsies: Is the Future Here Yet?
por: El Hajj, Ihab I., et al.
Publicado: (2019)

Commentary: Virtual reality in presurgical planning: The future is already here
por: Farooqi, Kanwal M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1mneok1bso3j890h42fpuqe59b